FdaApplication
NDA 214876
Identifiers
- fda_app_no: NDA214876
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE LLC |
| application_type | NDA |
| approval_date | 2023-04-26 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZEJULA | NIRAPARIB TOSYLATE | EQ 100MG BASE | TABLET;ORAL |
| ZEJULA | NIRAPARIB TOSYLATE | EQ 200MG BASE | TABLET;ORAL |
| ZEJULA | NIRAPARIB TOSYLATE | EQ 300MG BASE | TABLET;ORAL |
3 products